Benjamin Barker
About Benjamin Barker
Benjamin Barker is the Director of Digital Marketing - Oncology DTC Engagement at Bristol Myers Squibb, with extensive experience in digital marketing for oncology and a strong background in pharmaceutical marketing.
Company
Currently, Benjamin Barker is working at Bristol Myers Squibb as the Director of Digital Marketing - Oncology DTC Engagement. Bristol Myers Squibb is a globally renowned pharmaceutical company, where Barker plays a pivotal role in direct-to-consumer (DTC) marketing for oncology.
Title
Benjamin Barker holds the title of Director of Digital Marketing - Oncology DTC Engagement at Bristol Myers Squibb. His current role involves overseeing digital marketing initiatives targeting oncology patients, aimed at enhancing patient engagement and ensuring the effective communication of treatment options.
Career Progression at Bristol Myers Squibb
Before assuming his current role, Benjamin Barker served in various capacities at Bristol Myers Squibb. He was the Engagement Lead for Solid Tumors and earlier was the Associate Director, Digital Lead for Oncology Launch. Barker also held positions such as Lung Digital Lead and Digital Marketing lead for Opdivo Solid Tumors. Each role contributed to his extensive expertise in digital marketing within the oncology sector.
Experience in Pharmaceutical Marketing
Prior to his tenure at Bristol Myers Squibb, Barker worked at Zoetis as a Marketing Manager focusing on antiemetics and oncology. He also served as an Associate Product Manager at Pfizer, where he developed product management skills crucial for pharmaceutical marketing. These positions have given him a robust foundation in managing marketing strategies for pharmaceutical products.
Educational Background
Benjamin Barker earned his Master of Business Administration (MBA) from the University of South Carolina-Columbia, where he focused on Business - Marketing, Strategy, and Finance. He holds an MSc in Molecular Parasitology and Vector Biology from The University of Manchester and a Bachelor's degree in Biology and Communications from Oregon State University. His diverse educational background contributes to his comprehensive understanding of both the scientific and business aspects of pharmaceutical marketing.